T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapyGuido Ghilardi, Marco Ruella, Joseph A. Fraietta et al.|Nature Medicine|2024Cited by 254
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell TransplantationMarlise R. Luskin, Ran Reshef, David Porter et al.|Biology of Blood and Marrow Transplantation|2016Cited by 38
NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic featuresMarlise R. Luskin, Alexander E. Perl, Auris Huen et al.|Haematologica|2015Cited by 34
Interim analysis of LimiTec, a prospective trial of limited-duration teclistamab for relapsed/refractory multiple myelomaBeatrice M. Razzo, Alfred L. Garfall, Rajshekhar Chakraborty et al.|Blood|2025Cited by 6